The Elevated PSA Pathway and My Initial Experience with the EpiSwitch PSE Test

madman · Feb 15, 2025

Prostate cancer screening is an essential aspect of men’s health, and current advancements in testing are making early detection more precise than ever before.

While the PSA (Prostate-Specific Antigen) test has long been the standard, it has limitations and may lead to unnecessary biopsies. The new EpiSwitch PSE test helps differentiate between high and low prostate cancer risks. With an impressive 94% accuracy rate, the EpiSwitch PSE test empowers patients and physicians to make informed decisions.

In this episode, Dr. Garrett Pohlman explores the latest innovations in prostate cancer screening, focusing on the EpiSwitch PSE blood test.

Stay tuned to discover the benefits of the new EpiSwitch PSE test and learn how precision medicine is reshaping prostate cancer management for men

Show Highlights:

* What are the limitations of the PSA test?

* How the EpiSwitch PSE test can predict the risk of prostate cancer with 94% accuracy

* How prostate cancer biomarkers help to identify the likelihood of prostate cancer

* How the EpiSwitch PSE test can provide a more accurate assessment of prostate cancer risk

* How the EpiSwitch PSE test can help men avoid unnecessary biopsies

* The clinical applications of the EpiSwitch PSE test and how it can be used alongside a standard PSA test to improve accuracy

* How the EpiSwitch PSE test requires just two milliliters of blood

* How even patients who have undergone recent BPH procedures or are on 5-alpha reductase inhibitors can use the EpiSwitch PSE test

* Why the EpiSwitch PSE test is more accurate than PSA testing

* Why men need to be aware of their PSA numbers and consider additional testing if they have an elevated PSA

madman · Feb 15, 2025

Thread 'New Prostate Cancer Screening Test with 94% Accuracy'

Dec 14, 2023

We are delighted to partner with Oxford Biodynamics for today’s episode with Dr. Robert Heaton, who joins us to discuss a ground-breaking new prostate cancer screening test that predicts the risk of prostate cancer with 94% accuracy, using a simple blood test.

Dr. Heaton is a board-certified pathologist. He completed his medical training at Georgetown University and then spent the next twenty years in the US Navy. After finishing his residency training in pathology, Dr. Heaton became the Director of Laboratory and Clinical Support Services for...